Govt Bans 35 Combination Drugs, See Full List Farhat Nasim16 April 2025 8:36 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a stern directive to all State and Union Territory Drug...
Post hoc Analysis: Use of Bisoprolol in NOCAD Deeksha Bhandari24 Jan 2025 11:51 AM ISTBisoprolol is clinically feasible option in reducing resting heart rate (RHR) and improving left ventricular ejection fraction (LVEF), thereby...
Servier Introduces Cosyrel: A Novel SPC for Hypertension and Post-MI Care Deeksha Bhandari16 Jan 2025 2:59 PM ISTServier India Pvt. Ltd. has launched a single-pill combination (SPC) of Bisoprolol/Perindopril in India under the brand name Cosyrel, which is...
Exemed Pharmaceutical Gets CDSCO Panel Nod To Manufacture, Market Amlodipine, Bisoprolol FDC Dr. Divya Colin28 Dec 2024 6:00 PM ISTNew Delhi: Considering the request for bioequivalence (BE) and Phase III clinical trial (CT) waiver, the Subject Expert Committee (SEC) functional...
Metoprolol Safer Beta Blocker for Asthma Patients, Surprising Findings from FDA's large database MD Brand Connect19 Dec 2024 12:54 PM ISTMetoprolol Safer Beta Blocker for Asthma Patients, Reveals FAERS Database Analysis.A new analysis of the FDA's Adverse Event Reporting System (FAERS)...
Single tablet with 4 BP lowering drugs can be more effective than taking 3 drugs in separate pills: ESC 2024 Dr. Kamal Kant Kohli4 Sept 2024 5:15 AM ISTA single-pill combination of four blood-pressure (BP)-lowering medications was significantly more effective than a combination of three medications,...
Akums Drugs and Pharmaceuticals Gets CDSCO Panel Nod To study Dapagliflozin plus Bisoprolol FDC Dr. Divya Colin12 Jun 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted permission to the...
Bisoprolol fails to improve outcomes in COPD patients at high risk of exacerbations: BICS trial Medha Baranwal28 May 2024 9:45 PM ISTUK: In a landmark advancement in managing chronic obstructive pulmonary disease (COPD), the findings of the BICS (Bisoprolol in COPD Study) randomized...
Justify Sample Size: CDSCO Panel Tells Windlas Biotech on Cardiovascular FDC Dr. Divya Colin19 May 2024 5:45 PM ISTNew Delhi: Reviewing the bioequivalence (BE) study report of the fixed-dose combination (FDC) of cardiovascular drug Bisoprolol Fumarate...
Bisoprolol safe and effective for treating chronic obstructive pulmonary disease: Study Medha Baranwal2 May 2024 5:45 AM ISTChina: A recent meta-analysis published in the International Journal of Chronic Obstructive Pulmonary Disease has shown the safety and effectiveness...
Beta-blockers may reduce all-cause mortality in HFpEF patients Aditi19 Jan 2024 11:30 AM ISTAccording to the American and European heart failure guidelines, HFpEF is defined as a condition with LVEF >=50% and accompanying signs and...
Revise BE study protocol: CDSCO Panel tells Akum Pharma on FDC of Chlorthalidone, Cilnidipine, Bisoprolol film-coated tablet Dr. Divya Colin29 Dec 2023 5:00 PM ISTNew Delhi: Citing that individual and innovators' products should be taken as a reference product in the proposed bioequivalence study protocol, the...
